Order Article Reprints

Benyamine A, Bertin D, Resseguier N, Heim X, Bermudez J, Launay D, Dubucquoi S, Hij A, Farge D, Lescoat A, et al. Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis. Diagnostics. 2021; 11(6):1064. https://doi.org/10.3390/diagnostics11061064

Benyamine, Audrey, Daniel Bertin, Noémie Resseguier, Xavier Heim, Julien Bermudez, David Launay, Sylvain Dubucquoi, Adrian Hij, Dominique Farge, Alain Lescoat, and et al. 2021. "Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis" Diagnostics 11, no. 6: 1064. https://doi.org/10.3390/diagnostics11061064

Benyamine, A., Bertin, D., Resseguier, N., Heim, X., Bermudez, J., Launay, D., Dubucquoi, S., Hij, A., Farge, D., Lescoat, A., Bahon-Riedinger, I., Benmostefa, N., Mouthon, L., Harlé, J.-R., Kaplanski, G., Rossi, P., Bardin, N., & Granel, B. (2021). Quantification of Antifibrillarin (anti-U3 RNP) Antibodies: A New Insight for Patients with Systemic Sclerosis. Diagnostics, 11(6), 1064. https://doi.org/10.3390/diagnostics11061064